Hainan Haiyao Co. Ltd. A | Ownership
Companies that own Hainan Haiyao Co. Ltd. A
Yunnan International Trust Co., Ltd.
133,597,926
12.11%
133,597,926
4.51%
03/31/2018
Huaxin Trust Co., Ltd.
37,870,840
3.43%
37,870,840
5.09%
03/31/2018
SDIC Taikang Trust Co., Ltd.
31,943,494
2.9%
-33,044,669
10.58%
03/31/2018
Goldstate Capital Fund Management Co., Ltd.
13,082,500
1.19%
0
0.93%
03/31/2018
Manulife TEDA Fund Management Co., Ltd.
12,673,734
1.14%
-25,347,466
0.36%
03/31/2018
Lion Fund Management Co., Ltd.
4,284,535
0.39%
-504,284
0.2%
12/31/2017
ICBC Credit Suisse Asset Management Co., Ltd.
4,232,000
0.38%
-3,537,700
0.06%
12/31/2017
China Southern Asset Management Co., Ltd.
3,550,084
0.32%
-234,800
0.03%
12/31/2017
Beixin Ruifeng Fund Management Co. Ltd.
1,474,328
0.13%
971,465
0.03%
12/31/2017
Guotai Junan Allianz Fund Management Co., Ltd.
1,255,756
0.11%
-44,700
0.07%
12/31/2017
| Address |
No. 192 Nanhai Avenue
Haikou Hainan 570311
China
|
|
Employees
|
- |
| Website |
http://www.haiyao.com.cn |
| Updated |
07/08/2019 |
| Hainan Haiyao Co., Ltd. engages in the research, development, manufacture and sale of medicines and medical instrument. Its products consist of six categories, including cephalosporin series, stomach and intestine medicines, anti-tumor medicines, cochlear implant series, bulk drugs and intermediate series. The company was founded in 1965 and is headquartered in Haikou, China. |
